BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12533791)

  • 1. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
    Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
    Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset.
    Misawa H; Nakata K; Toda K; Matsuura J; Oda Y; Inoue H; Tateno M; Takahashi R
    Genesis; 2003 Sep; 37(1):44-50. PubMed ID: 14502577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and temporal activity of the dentin sialophosphoprotein gene promoter: differential regulation in odontoblasts and ameloblasts.
    Sreenath TL; Cho A; MacDougall M; Kulkarni AB
    Int J Dev Biol; 1999 Sep; 43(6):509-16. PubMed ID: 10610024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.
    Liu F; Woitge HW; Braut A; Kronenberg MS; Lichtler AC; Mina M; Kream BE
    Int J Dev Biol; 2004 Sep; 48(7):645-53. PubMed ID: 15470637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
    Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
    Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
    Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
    Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural expression of alpha-internexin promoter in vitro and in vivo.
    Wang P; Wang SM; Hsieh CJ; Chien CL
    J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of Cre recombinase in mitral/tufted cells of the olfactory bulb.
    Nagai Y; Sano H; Yokoi M
    Genesis; 2005 Sep; 43(1):12-6. PubMed ID: 16106355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system.
    Banares S; Zeh K; Krajewska M; Kermer P; Baribault H; Reed JC; Krajewski S
    Genesis; 2005 May; 42(1):6-16. PubMed ID: 15828007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
    Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.